Importance of valine at position 152 for the substrate transport and 2β-carbomethoxy-3β-(4-fluorophenyl)tropane binding of dopamine transporter

Molecular Pharmacology

Volumn 57, Issue 5, 2000, Pages 883-889

  Lee, Sang Hun ^a   Chang, Mi Yoon ^a   Lee, Ki Hwan ^a   Park, Byung Sup ^a   Lee, Young Seek ^a   Chin, Hemin R ^b   Lee, Yong Sung ^a  

^a Hanyang University   (South Korea)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 3BETA (4 FLUOROPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; AMINO ACID; COCAINE DERIVATIVE; DOPAMINE; DOPAMINE TRANSPORTER; ISOLEUCINE; VALINE;

AMINO ACID SUBSTITUTION; ARTICLE; BINDING AFFINITY; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; CATTLE; COCAINE; COS CELLS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; HUMANS; ISOLEUCINE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; NERVE TISSUE PROTEINS; RECOMBINANT FUSION PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; VALINE;

EID: 0034015391     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Amara SG and Kuhar MJ (1993) Neurotransmitter transporters: Recent progress. Annu Rev Neurosci 16:73-93.
2. Barker EL, Kimmel HL and Blakely RD (1994) Chimeric human and rat serotonin transporters reveal domains involved in recognition of transporter ligands. Mol Pharmacol 46:799-807.
3. Barker EL, Moore KR, Rakhshan F and Blakely RD (1999) Transmembrane doamine I contributes to the permeation pathway for serotonin and ions in the serotonin transporter. J Neurosci 19:4705-4717.
4. Barker EL, Perlman MA, Adkins EM, Houlihan WJ, Pristupa ZB, Niznik HB and Blakely RD (1998) High affinity recognition of serotonin transporter antagonists defined by species-scanning mutagenesis. J Biol Chem 273:19459-19468.
5. -) coupled γ-aminobutyric acid transporter from rat brain. J Biol Chem 272: 1203-1210.
6. Buck KJ and Amara SG (1994) Chimeric dopamine-norepinephrine transporters delineate structural domains influencing selectivity for catecholamines and 1-methyl-4-phenylpyridium. Proc Natl Acad Sci USA 91:12584-12588.
7. Buck KJ and Amara SG (1995) Structural domains of catecholamine transporter chimeras involved in selective inhibition by antidepressants and psychomotor stimulants. Mol Pharmacol 48:1030-1037.
8. Chen JG, Sachpatzidis A and Rudnick G (1997) The third transmembrane domain of the serotonin transporter contains residues associated with substrate and cocaine binding. J Biol Chem 272:28321-28327.
9. Clark JA (1997) Analysis of the transmembrane topology and membrane assembly of the GAT-1 γ-aminobutyric acid transporter. J Biol Chem 272:14695-14704.
10. DePaulis T, Kelder D and Ross SB (1978) On the topology of the norepinephrine transport carrier in rat hypothalamus: The site of action of tricyclic uptake inhibitors. Mol Pharmacol 14:596-606.
11. Gether U and Kobilka BK (1998) G protein-coupled receptors; II. Mechanisms of agonist activation. J Biol Chem 273:17979-17982.
12. Giros B and Caron MG (1993) Molecular characterization of dopamine transporter. Trends Pharmacol Sci 14:43-49.
13. Giros B, Mestikawy S, Godinot N, Zheng K, Han H, Yang-Feng T and Caron MG (1992) Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. Mol Pharmacol 42:383-390.
14. Giros B, Wang Y-M, Suter S, McLeskey SB, Pifl C and Caron MG (1994) Delineation of discrete domains for substrate, cocaine, and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters. J Biol Chem 269: 15985-15988.
15. Horn AS (1990) Dopamine uptake: A review of progress in the last decade. Prog Neurobiol 34:387-400.
16. Iversen LL (1992) Role of transmitter uptake mechanisms in synaptic neurotransmission. Br J Pharmacol 41:571-591.
17. Jayanthi LD, Apparsundaram S, Malone MD, Ward E, Miller DM, Eppler M and Blakely RD (1998) The Caenorhabditis elegans gene T23G5.5 encodes an antidepressant-and cocaine-sensitive dopamine transporter. Mol Pharmacol 54:601-609.
18. Ji TH, Grossmann M and Ji I (1998) G protein-coupled receptors: I. Diversity of receptor-ligand interactions. J Biol Chem 273:17299-17302.
19. Johnstone R (1990) Ion-coupled cotransporter. Curr Opin Cell Biol 2:735-741.
20. Kanner BI and Schuldiner S (1987) Mechanism of transporter and storage of neurotransmitter. Crit Rev Biochem 22:1-38.
21. +: Uptake and toxicity in nonneuronal COS cells expressing dopamine transporter cDNA. Ann Neurol 32:109-111.
22. Kitayama S, Shimada S, Xu H, Markham L, Donovan DM and Uhl GR (1992b) Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding. Proc Natl Acad Sci USA 89:7782-7785.
23. + transport. Synapse 15:58-62.
24. Kuhar MJ and Zarbin MA (1978) Synaptosomal transporter: A chloride dependence for choline, GABA, glycine, and several other compounds. J Neurochem 31:251-256.
25. Lee SH, Kang SS, Son H and Lee YS (1998) The region of dopamine transporter encompassing the 3rd transmembrane domain is crucial for function. Biochem Biophys Res Commun 246:347-352.
26. + uptake and cocaine binding in bovine dopamine transporter. Neurosci Lett 214:199-201.
27. Maxwell RA, Ferris RM and Burscu JE (1976) Mechanism of Neuronal and Extraneuronal Transport of Catecholamines, pp 95-153, Raven Press, New York.
28. Pifl C, Giros B and Caron MG (1996) The dopamine transporter: The cloned target site of Parkinsonism-inducing toxins and of drugs of abuse. Adv Neurol 69:235-238.
29. Prasher DC, Eckenrode VK, Ward WW, Prendergast FG and Cormier MJ (1992) Primary structure of the Aequorea victoria green fluorescent protein. Gene 111: 229-233.
30. Shimada S, Kitayama S, Lin CL, Patel A, Nanthakumar E, Gregor P, Kuhar M and Uhl G (1991) Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA. Science (Wash DC) 254:576-578.
31. Snyder SH and D'Amato RJ (1986) MPTP: A neurotoxin relevent to the pathophysiology of Parkinson's disease. Neurology 36:250-258.
32. Uhl GR (1992) Neurotransmitter transporters (plus) promising new gene family Trends Neurosci 15:265-268.
33. Uhl GR and Hartig PR (1992) Transporter explosion: Update on uptake. Trends Pharmacol Sci 13:421-425.
34. Wang JB, Moriwaki A and Uhl GR (1995) Dopamine transporter cysteine mutants: Second extracellular loop cysteines are required for transporter expression. J Neurochem 64:1416-1419.